NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.

Current Quarter	$NA	Next Quarter	$NA
Current Year	$-0.13	Next Year	$-0.15
QoQ Growth	NaN%	YoY Growth	-15.4%
3Y EPS CAGR	+20.9%	Target Price	$2.23
Consensus	Buy	Upside	+239.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NMTC	$0.66	+12.38%	401.73K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NMTC	$0.66	+12.4%	401.73K
3
4
5
6

NMTC

NMTC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get NeuroOne Medical Technologies Corporation Data in Excel

Get NeuroOne Medical Technologies Corporation Data in Excel